Skip to main content
Supplement ScienceSupplementScience

MCT Oil Research & Evidence

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Moderate

MCT Oil has a moderate-to-strong evidence base for metabolic effects and emerging evidence for cognitive support. A 2015 meta-analysis of 13 randomized controlled trials (n=749) by Mumme et al. demonstrated that replacing long-chain triglycerides with medium-chain triglycerides modestly reduced body weight, waist circumference, hip circumference, total body fat, subcutaneous fat, and visceral fat in adults. The cognitive benefits are particularly promising: a 2004 study by Reger et al. showed that a single dose of MCTs improved cognitive performance in APOE4-negative Alzheimer's patients, and subsequent trials have explored sustained MCT supplementation for mild cognitive impairment.

The ketogenic mechanism is well-understood — C8 is converted to beta-hydroxybutyrate (BHB) in the liver, which crosses the blood-brain barrier and serves as an alternative fuel for glucose-impaired neurons. Key limitations include heterogeneity in MCT compositions across studies, most trials using mixed C8/C10/C12 products rather than pure C8, and limited long-term safety data above 30ml/day.

A Phase II crossover study by Tosefsky et al. (2026) involving 52 individuals with Parkinson's disease found that both Mediterranean-ketogenic diets were safe but showed low feasibility due to high dropout rates and modest adherence. A randomized clinical trial by Rafieipoor et al. (2024) involving 112 hemodialysis patients found no effect of omega-3 supplementation on chronic kidney disease-associated pruritus.

A 2023 randomized clinical trial by Wendel et al. (n=120) found that ARA and DHA supplementation reduced respiratory support duration and oxygen demand in preterm infants without affecting BPD incidence. Another study by Wendel et al. (2023) involving 120 preterm infants found that essential fatty acid supplementation reduced IL-6 levels, suggesting potential anti-inflammatory effects.

Overall, MCT oil shows promise for metabolic and cognitive benefits, but further research is needed to address limitations in composition consistency and long-term safety.

Evidence by Condition

ConditionStudied DoseEvidence
Cognitive support20-30ml (1-2 tbsp) C8 oil dailyEmerging
Weight management15-30ml daily, taken before mealsModerate
Quick energy / ketone boost10-15ml (1 tbsp) as neededModerate
Exercise endurance15-30ml taken 30-60 min before exerciseEmerging
See which MCT Oil products match the research
Products ranked against the clinical evidence

References

  1. Meta-analysisMumme K, Stonehouse W (2015). Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. Journal of the Academy of Nutrition and Dietetics. DOI PubMed
  2. RCTReger MA, Henderson ST, Hale C, et al. (2004). Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiology of Aging. DOI PubMed
  3. RCTSt-Onge MP, Bosarge A (2008). Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. American Journal of Clinical Nutrition. DOI PubMed
  4. RCTOta M, Matsuo J, Ishida I, et al. (2019). Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease. Neuroscience Letters. DOI PubMed
  5. ReviewClegg ME (2010). Medium-chain triglycerides are advantageous in promoting weight loss although not beneficial to exercise performance. International Journal of Food Sciences and Nutrition. DOI PubMed
  6. Courchesne-Loyer A, Fortier M, Tremblay-Mercier J, et al. (2013). Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism. Nutrition. DOI PubMed
  7. Vandenberghe C, St-Pierre V, Pierotti T, Fortier M, Castellano CA, Cunnane SC (2017). Tricaprylin Alone Increases Plasma Ketone Response More Than Coconut Oil or Other Medium-Chain Triglycerides. Current Developments in Nutrition. DOI PubMed
Show 5 more references
  1. Tosefsky K, Lam JS, Wang YN, Keymanesh S, et al. (2026). A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease.. Journal of Parkinson's disease. DOI PubMed
  2. Rafieipoor A, Torkaman M, Azaryan F, Tavakoli A, et al. (2024). Effectiveness of omega-3 fatty acid supplementation for pruritus in patients undergoing hemodialysis.. Frontiers in nutrition. DOI PubMed
  3. Wendel K, Gunnarsdottir G, Fossan Aas M, Westvik ÅS, et al. (2023). Essential Fatty Acid Supplementation and Early Inflammation in Preterm Infants: Secondary Analysis of a Randomized Clinical Trial.. Neonatology. DOI PubMed
  4. Rasmussen E, Patel V, Tideman S, Frech R, et al. (2023). Efficacy of supplemental MCT oil on seizure reduction of adult drug-resistant epilepsy - a single-center open-label pilot study.. Nutritional neuroscience. DOI PubMed
  5. Lapillonne A, et al. (2023). Effect of arachidonic and docosahexaenoic acid supplementation on respiratory outcomes in preterm infants.. Journal of pediatrics. DOI PubMed